MAOB and Parkinson disease: Our results extend these findings by showing that MAO-B inhibitors as an adjunct to levodopa have a better effect on cognitive function (including probabilistic learning, forward and backward digit span, n-back, WCST-64, FAB, Trail Making B) in PD patients than levodopa or DA agonists monotherapy.